United Therapeutics Authorizes New $2B Share Repurchase Program Through October 21, 2027
Share
Why It Matters
United Therapeutics said it will buy back two billion dollars of its own stock. This shows the company feels confident about its future and has extra cash.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.